MECP2 and Rett syndrome: These studies, using genetic animal models of Rett syndrome, Mecp2-308 mice [184,185], demonstrated that subchronic administration of 5-HT7 agonist displayed persistent effects related to Rett syndrome, a result of increasing motivation regarding the development of 5-HT7 agonists for the treatment of Rett syndrome.